Use Of Bio D® In Sea Bream (Sparus Aurata): Effects On Growth Performance And Vitamin Retention In Tissues And Skeletal Abnormalities

reading time
Article | 05.12.2024
Nowadays, the substitution of fish meal and fish oil with plant-based ingredients in marine fish feed is key for sustainable production and decreasing feed costs. However, this substitution changes the vitamin profile of the feed, leading to the need for supplementation to meet vitamin requirements, including vitamin D.

Cholecalciferol (vitamin D3) is traditionally used as a vitamin D supplement in aquaculture feed. Once ingested by the fish, two steps of hydroxylation using hydroxylase enzymes are necessary to convert cholecalciferol, via calcifediol (25-OH-D3) into calcitriol (1,25-OH-D3). By supplementing the feed directly with Bio D® (calcifediol), one of the two hydroxylation processes is avoided, improving the activity of the vitamin.

There is evidence to suggest that direct dietary calcifediol supplementation in higher vertebrates is effective at promoting performance, improving bone mineralisation, and reducing the incidence of tibial dyschondroplasia (Atencio et al., 2005; Han et al., 2016) and modulating avian immunity (Gómez-Verduzco et al., 2013; Leyva-Jiménez et al., 2019; Hashim et al., 2022). However, this had not been tested in Mediterranean aquaculture species until the present work which shows the first evidence of the positive effects of this compound on juvenile sea bream.

 

Materials and method

In this study, 360 juvenile sea bream (Sparus aurata), weighing 12.8 ± 1.5 g were distributed across nine tanks in groups tripled per diet, and fed either a control diet or one of two diets containing different levels of Bio D (99.7 and 167.4 ppb). Feeding was until apparent satiety three times a day for 105 days under a natural photoperiod (12 hours of light). 

At the end of the trial, feed conversion rate (FCR), specific growth rate (SGR) and fish proximal composition were calculated. 

Table 1. Feed composition

 

Results and discussion

At the end of the trial, fish fed the diet containing 99.7 ppb of Bio D (calcifediol) showed the highest weight, which was significantly higher than the control group (Table 1) and led to a higher biomass production. 

Fish had a total weight gain of up to 528.9 ± 27.3 (%) at the end of the trial, although this was not significantly different between treatments (Table 2). The lowest FCRs were observed in the fish fed diets containing Bio D, also leading to better feed performance.

Table 2. Zootechnical performance of sea bream using different levels of Bio D®. Different letters in the same row indicate significant differences for ANOVA analysis (< 0.05). values are of the most significant results

An increase in vitamin D3 content in the fish was observed associated with the increase in Bio D in the diet. The calcium content in the vertebrae increased to the level of 99.7 and 167.4 ppb (Table 3). Better calcium retention plays a key role in skeletal mineralisation and is linked with bone strength and growth in fish.

Table 3. Lipids in fillet, vitamin D in fish, and calcium in vertebrae of sea bream at the end of the trial. Different letters in the same row indicate significant differences for ANOVA analysis (< 0.05). values are of the most significant results

 

Conclusion

  • The inclusion level of 99.7 ppb of Bio D is recommended to improve growth, FCR and calcium levels in the vertebrae. 
  • Calcium content of bone increases with the use of Bio D at 99.7 and 167.4 ppb. Calcium plays a key role in normal bone development, potentially leading to fewer skeletal deformities and normal growth.

 

global presence

Local support from a global company

Huvepharma® has a distribution network which covers more than 90 countries in 6 continents. Find your nearest Huvepharma® representative today.
Find your local contact
about us

Huvepharma®

Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.
more about us

Change country

The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.

To view all products and services, select Global from the dropdown menu or click .

Africa

Asia

Europe

North America

Oceania

South America

Change language

Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.

Europe

United States

Click here to visit the local website or close this popup to stay on the global website.

top
Your browser is out of date!

Update your browser to view this website correctly. Update my browser now